Dr. Jeffrey Freitag named chief medical officer of PharmaNet

Tuesday, March 8, 2011 10:57 AM

PharmaNet Development Group, a provider of pharmaceutical services to biotechnology, generic drug and medical device companies, has promoted Jeffrey Freitag, M.D., senior vice president of PharmaNet Consulting, to chief medical officer.

Dr. Freitag will be the senior medical representative and guide physicians involved in phase I through phase III clinical trials. He will retain his current responsibilities heading the team of regulatory and pharmaceutical consultants.

Dr. Freitag has worked in the pharmaceutical industry for more than 25 years, including positions as vice president of clinical drug development at The Liposome Company and vice president of R&D at Bone Care International.  He is board certified in Internal Medicine and Nephrology.

 

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs